Patents
Patents for C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
08/2007
08/15/2007CN1331848C Tricyclic steroid hormone nuclear receptor modulators
07/2007
07/11/2007EP1686983B1 Use of pentadienoic acid derivates for treatement of hyperuricemia
06/2007
06/27/2007CN1986542A Preparing process of 2-(10-oxy-10,11-dihydrodibenz [b,f]-thiotropilium-2-yl) propionic acid
06/27/2007CN1986528A Preparing process of 5-propionyl-2-thiophenyl phenylacetate
06/13/2007EP1794137A2 Specific kinase inhibitors
06/06/2007CN1319964C Preparation of 10,11-dihydrodibenzo[b,f] cyproheptadine-10-ketone compound
06/05/2007US7226943 Antilipemic agents
05/2007
05/03/2007US20070099854 Use of pentadienoic acid derivatives for the treatment of hyperuricemia
04/2007
04/26/2007WO2007047737A1 Cb-1 modulating compounds and their use
04/26/2007CA2625423A1 Cb-1 modulating compounds and their use
03/2007
03/28/2007CN1307171C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
02/2007
02/28/2007CN1301997C Benzosulfones with calcium antagonist activity
02/20/2007US7179792 Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least one other active ingredient and the use of the product
02/14/2007CN1911930A Chemokine receptor anagonists, methods and use therefor
01/2007
01/30/2007CA2286723C Tricyclic compounds
01/23/2007US7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
01/16/2007CA2257234C Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
12/2006
12/27/2006CN1886129A Use of pentadienoic acid derivates for treatment of hyperuricemia
11/2006
11/23/2006WO2006122776A1 Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs
11/23/2006DE102005023944A1 Substituierte benzokondensierte Cycloheptanon-Derivate und deren Verwendung zur Herstellung von Arzneimitteln Substituted benzofused cycloheptanone derivatives and their use for the preparation of medicaments
11/23/2006DE102005022020A1 New dibenzocycloheptane compounds are tumor necrosis factor-alpha inhibitors useful to treat e.g. cancer, rheumatic arthritis, gout, septic shock, osteoporosis, naturopathic pain, HIV-propagation and periodontal diseases
11/22/2006CN1865257A Cyclopropanated macrocyclic ketones and lactones
11/15/2006EP1427718B1 Benzothiepine ileal bile acid transport inhibotors
11/08/2006EP1719768A1 Novel benzothiazepine and benzothiepine compounds
11/02/2006EP1127045B1 Triphenylbutene derivatives for the treatment of neurological disorders
10/2006
10/26/2006WO2006036941A3 Specific kinase inhibitors
09/2006
09/14/2006US20060205756 Antitussives
09/13/2006EP0979821B1 Tricyclic compounds
08/2006
08/24/2006WO2006004774A3 Laulimalide analogues as therapeutic agents
08/23/2006EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same
08/09/2006EP1688418A2 Chemokine receptor antagonists and methods of use thereof
08/09/2006EP1686983A1 Use of pentadienoic acid derivates for treatement of hyperuricemia
08/08/2006US7087765 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
07/2006
07/19/2006EP1325054B1 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers
06/2006
06/29/2006US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/21/2006CN1260220C Tricyclic compounds
05/2006
05/04/2006US20060094884 Benzothiazepine and benzothiepine derivatives
04/2006
04/20/2006US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
04/18/2006CA2207443C Tricyclic compounds
04/06/2006CA2581375A1 Specific kinase inhibitors
03/2006
03/28/2006US7019023 Benzothiepine 1, 1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
03/23/2006US20060063937 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/15/2006EP1448566B1 Chemokine receptor antagonists and methods of use thereof
03/15/2006CN1746165A Preparation of 10,11-dihydrodibenzo[b,f] cyproheptadine-10-ketone compound
01/2006
01/04/2006EP1611888A1 Antitussives
01/03/2006CA2093577C Alkyl or alkoxy substituted s-heterocyclic retinoids
12/2005
12/29/2005US20050288522 Process for preparing pentacene derivatives
12/13/2005US6974877 Such as 1,4,8,11-tetramethylpentacene by reacting substituted bis(benzyl)phthalic acid with trifluoromethanesulfonic acid
11/2005
11/23/2005EP1597245A1 Benzothiazepine and benzothiepine derivatives
11/16/2005EP1492795B1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/2005
10/26/2005EP1587798A2 Geminally di-substituted nsaid derivatives as abeta 42 lowering agents
09/2005
09/27/2005US6949291 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers
09/13/2005US6943189 mixture of sulfur compounds and 3-hydroxy-3-methylglutaryl-coenzyme A inhibitors, used for prophylaxis of hyperlipemia in mammals
09/09/2005WO2005082874A1 Novel benzothiazepine and benzothiepine compounds
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/01/2005WO2005079785A1 Remedies for hyperuricemia and/or gout
08/2005
08/31/2005EP1182200B1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
08/31/2005EP0888333B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
08/17/2005CN1655792A Combination product of a 1, 4-benzothiepine 1, 1-dioxide compound with at least one other active ingredient and the use of the product
08/03/2005CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/02/2005CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
06/2005
06/23/2005US20050137249 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1; nontoxic
06/16/2005WO2005053676A1 Use of pentadienoic acid derivatives for the treatment of hyperuricemia
06/16/2005US20050130964 e.g 8-oxa-1-thia-benzo[e]naphtho[3,2-h]azulene-2-carboxylic acid ethyl ester; rheumatoid arthritis
06/16/2005US20050130956 1-oxa 3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
06/16/2005CA2547543A1 Use of pentadienoic acid derivatives for the treatment of hyperuricemia
06/01/2005EP1535612A1 Treatment for hyperuricemia
05/2005
05/10/2005US6890952 Administering cyclic substituted aminomethyl compounds for the preparation of a drug for the treatment of pain, urinary incotinence, itching, tinnitus aurium or diarrhea in a mammal
05/10/2005US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1
04/2005
04/28/2005US20050090543 Method for the preparation of tetrahydrobenzothiepines
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/05/2005US6875877 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
03/2005
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/09/2005CN1592729A Process for preparing pentacene derivatives
03/09/2005CN1192027C Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
03/03/2005US20050049146 E.g., 7-fluoro-10-(4-ethylpiperazine)-dibenzo(b,f)thiepine as well as analogues based on dibenzo(b,f)oxepin, dibenzo(b,f)azepin and dibenzo(a,d)cycloheptene; parasiticides; pesticides; protecting crops; along with an agronomically acceptable carrier
02/2005
02/24/2005US20050043548 For analyzing illegal or undesirable content; control station sends enforcement order to traffic controller, which executes enforcement rule by limiting access of a network code
02/24/2005US20050043393 Antilipemic agents
02/23/2005CN1585772A Chemokine receptor antagonists and methods of use thereof
02/16/2005CN1582283A Benzothiepine ileal bile acid transport inhibitors
02/10/2005WO2005011674A1 Preventive and/or therapeutic agents for bronchial asthma
02/08/2005US6852753 Treating hyperlipidemic condition, gallstones
01/2005
01/19/2005CN1184967C Tracheal smooth muscle relaxant
01/12/2005EP1299373B1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds
01/05/2005EP1492795A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/2004
12/23/2004WO2004064771A3 Geminally di-substituted nsaid derivatives as abeta 42 lowering agents
12/15/2004CN1554651A Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
12/15/2004CN1179958C Cyclic substituted aminomethyl compounds and medicaments containing said compounds
11/2004
11/18/2004US20040229899 Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
11/03/2004CN1173967C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
10/2004
10/14/2004WO2004087131A1 Antitussives
10/14/2004US20040204478 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
10/14/2004CA2520680A1 Antitussives
10/13/2004EP1466911A2 Preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
10/13/2004EP1465885A2 Novel alkyl/aryl hydroxy or keto thiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
10/07/2004US20040198974 applying deemed racemates to continuos enantioselective liquid chromatography like SMB (simulated moving bed); for industrial scale production of pure enantiomers of amino acids useful as intermediates in organic synthesis such as N-benzyloxycarbonyl-tert-leucine
09/2004
09/23/2004US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits
09/22/2004EP0879231B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
09/21/2004US6794544 Method for the preparation of tetrahydrobenzothiepines
1 2 3 4 5 6 7 8 9